Exabis Library
Welcome to the e-CCO Library!
DOP059: New human gut xenograft mouse model for intestinal fistulas
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP05: Adipose-derived stem cells from Crohn’s disease patients show antigen presenting cell-like properties
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP05: Adipose-derived stem cells from Crohn’s disease patients show antigen presenting cell-like properties
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP05: Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´s Disease.
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP05: Morbid obesity, a new susceptibility factor for developing Inflammatory Bowel Disease. Results of a population-based study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP05: Perioperative Dietary Therapy in Inflammatory Bowel Disease
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP05: Perioperative Dietary Therapy in Inflammatory Bowel Disease
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP05: Single-cell RNAseq temporal analysis of ulcerative colitis patients undergoing tofacitinib treatment reveals a shift in myeloid cells towards pro-inflammatory phenotypes in refractory patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP05: Single-cell RNAseq temporal analysis of ulcerative colitis patients undergoing tofacitinib treatment reveals a shift in myeloid cells towards pro-inflammatory phenotypes in refractory patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP05: Target engagement and pharmacodynamic biomarker analysis following treatment with the oral gut-targeted HIF-1α stabilizer GB004 in a Phase 1b trial in Active Ulcerative Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP06 Non-invasive identification of adherent-invasive E. coli in patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP060: Anti-TNF cord levels are significantly higher after IFX exposure during pregnancy compared with ADA exposure
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP060: Human amnion epithelial cells and their conditioned media reduces intestinal inflammation and fibrosis in a murine model of chronic colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP060: Real-world treatment pathway visualizations show low use of biologic therapies in Crohn's disease and ulcerative colitis in the United States
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP060: Real-world treatment pathway visualizations show low use of biologic therapies in Crohn’s Disease and Ulcerative Colitis in the United States
2017
ECCO'17 Barcelona
1
DOP061: Human amnion epithelial cells reduce intestinal inflammation in a 2,4,6-trinitrobenzene sulfonic acid induced model of Acute Colitis
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP061: Human amnion epithelial cells reduce intestinal inflammation in a 2,4,6-trinitrobenzene sulfonic acid induced model of acute colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP061: Intrauterine exposure to thiopurine: assessing health outcome of children born to patients with an inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP061: Phase III randomised, double-blind, controlled trial to compare biosimilar infliximab (CT-P13) with innovator infliximab in patients with active Crohn's disease: early efficacy and safety results
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM